
    
      The protocol involves assessment of effects of CG25 (subgenual cingulate area-Brodmann 25)
      DBS on mood, anxiety, apathy, anhedonia, psychomotor retardation, functional state as well as
      safety and tolerance by specific psychometric scores.

      Moreover the protocol aims at highlighting the neurocircuits modulated by CG25 DBS by means
      of PET (positron emission tomography) imagery
    
  